Drug Development Consulting and Preclinical Project Management Services

InSymbiosis’ drug development consulting services supports our clients’ needs from early phase drug discovery through to IND/IMPD and Phase 1. InSymbiosis has developed a unique approach to assisting their clients with their preclinical programs by combining scientific and consulting regulatory services with our “virtual” contract research organization (CRO) model, for a truly complete approach to drug development consulting. Key to InSymbiosis’ approach is our multidisciplinary team of expert drug developers and project managers who facilitate a seamless transition between preclinical program planning, execution and IND/IMPD preparation and filing. Further, InSymbiosis have developed a financial model that can facilitate our client’s cash flows and significantly reduce our client’s budgets via leveraging Canadian government financial incentives.